Lymphoma Therapeutics market worldwide is projected to grow by US$9. 3 Billion, driven by a compounded growth of 7. 7%. Hodgkin Lymphoma (HL), one of the segments analyzed and sized in this study, displays the potential to grow at over 7%.

New York, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Lymphoma Therapeutics Industry" - https://www.reportlinker.com/p05818005/?utm_source=GNW
The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$2.2 Billion by the year 2025, Hodgkin Lymphoma (HL) will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 6.5% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$323.7 Million to the region’s size and clout in the next 5 to 6 years. Over US$278.5 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Hodgkin Lymphoma (HL) will reach a market size of US$139.3 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 11.4% over the next couple of years and add approximately US$2.6 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, Celgene Corporation; F. Hoffmann-La Roche AG; Johnson & Johnson; Seattle Genetics, Inc.


Read the full report: https://www.reportlinker.com/p05818005/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Lymphoma Therapeutics Competitor Market Share Scenario
Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Lymphoma Therapeutics Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 2: Lymphoma Therapeutics Global Retrospective Market
Scenario in US$ Million by Region/Country: 2009-2017
Table 3: Lymphoma Therapeutics Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Hodgkin Lymphoma (HL) (Disease Type) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 5: Hodgkin Lymphoma (HL) (Disease Type) Historic Market
Analysis by Region/Country in US$ Million: 2009 to 2017
Table 6: Hodgkin Lymphoma (HL) (Disease Type) Market Share
Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS
2025
Table 7: Non-Hodgkin Lymphoma (NHL) (Disease Type) Potential
Growth Markets Worldwide in US$ Million: 2018 to 2025
Table 8: Non-Hodgkin Lymphoma (NHL) (Disease Type) Historic
Market Perspective by Region/Country in US$ Million: 2009 to
2017
Table 9: Non-Hodgkin Lymphoma (NHL) (Disease Type) Market Sales
Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Lymphoma Therapeutics Market Share (in %) by Company: 2019 &
2025
Table 10: United States Lymphoma Therapeutics Market Estimates
and Projections in US$ Million by Disease Type: 2018 to 2025
Table 11: Lymphoma Therapeutics Market in the United States by
Disease Type: A Historic Review in US$ Million for 2009-2017
Table 12: United States Lymphoma Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
CANADA
Table 13: Canadian Lymphoma Therapeutics Market Estimates and
Forecasts in US$ Million by Disease Type: 2018 to 2025
Table 14: Canadian Lymphoma Therapeutics Historic Market Review
by Disease Type in US$ Million: 2009-2017
Table 15: Lymphoma Therapeutics Market in Canada: Percentage
Share Breakdown of Sales by Disease Type for 2009, 2019, and
2025
JAPAN
Table 16: Japanese Market for Lymphoma Therapeutics: Annual
Sales Estimates and Projections in US$ Million by Disease Type
for the Period 2018-2025
Table 17: Lymphoma Therapeutics Market in Japan: Historic Sales
Analysis in US$ Million by Disease Type for the Period
2009-2017
Table 18: Japanese Lymphoma Therapeutics Market Share Analysis
by Disease Type: 2009 VS 2019 VS 2025
CHINA
Table 19: Chinese Lymphoma Therapeutics Market Growth Prospects
in US$ Million by Disease Type for the Period 2018-2025
Table 20: Lymphoma Therapeutics Historic Market Analysis in
China in US$ Million by Disease Type: 2009-2017
Table 21: Chinese Lymphoma Therapeutics Market by Disease Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Lymphoma Therapeutics Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Table 22: European Lymphoma Therapeutics Market Demand Scenario
in US$ Million by Region/Country: 2018-2025
Table 23: Lymphoma Therapeutics Market in Europe: A Historic
Market Perspective in US$ Million by Region/Country for the
Period 2009-2017
Table 24: European Lymphoma Therapeutics Market Share Shift by
Region/Country: 2009 VS 2019 VS 2025
Table 25: European Lymphoma Therapeutics Market Estimates and
Forecasts in US$ Million by Disease Type: 2018-2025
Table 26: Lymphoma Therapeutics Market in Europe in US$ Million
by Disease Type: A Historic Review for the Period 2009-2017
Table 27: European Lymphoma Therapeutics Market Share Breakdown
by Disease Type: 2009 VS 2019 VS 2025
FRANCE
Table 28: Lymphoma Therapeutics Market in France by Disease
Type: Estimates and Projections in US$ Million for the Period
2018-2025
Table 29: French Lymphoma Therapeutics Historic Market Scenario
in US$ Million by Disease Type: 2009-2017
Table 30: French Lymphoma Therapeutics Market Share Analysis by
Disease Type: 2009 VS 2019 VS 2025
GERMANY
Table 31: Lymphoma Therapeutics Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Disease Type for
the Period 2018-2025
Table 32: German Lymphoma Therapeutics Historic Market Analysis
in US$ Million by Disease Type: 2009-2017
Table 33: German Lymphoma Therapeutics Market Share Breakdown
by Disease Type: 2009 VS 2019 VS 2025
ITALY
Table 34: Italian Lymphoma Therapeutics Market Growth Prospects
in US$ Million by Disease Type for the Period 2018-2025
Table 35: Lymphoma Therapeutics Historic Market Analysis in
Italy in US$ Million by Disease Type: 2009-2017
Table 36: Italian Lymphoma Therapeutics Market by Disease Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 37: United Kingdom Market for Lymphoma Therapeutics:
Annual Sales Estimates and Projections in US$ Million by
Disease Type for the Period 2018-2025
Table 38: Lymphoma Therapeutics Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Disease Type for the
Period 2009-2017
Table 39: United Kingdom Lymphoma Therapeutics Market Share
Analysis by Disease Type: 2009 VS 2019 VS 2025
SPAIN
Table 40: Spanish Lymphoma Therapeutics Market Estimates and
Forecasts in US$ Million by Disease Type: 2018 to 2025
Table 41: Spanish Lymphoma Therapeutics Historic Market Review
by Disease Type in US$ Million: 2009-2017
Table 42: Lymphoma Therapeutics Market in Spain: Percentage
Share Breakdown of Sales by Disease Type for 2009, 2019, and
2025
RUSSIA
Table 43: Russian Lymphoma Therapeutics Market Estimates and
Projections in US$ Million by Disease Type: 2018 to 2025
Table 44: Lymphoma Therapeutics Market in Russia by Disease
Type: A Historic Review in US$ Million for 2009-2017
Table 45: Russian Lymphoma Therapeutics Market Share Breakdown
by Disease Type: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 46: Rest of Europe Lymphoma Therapeutics Market Estimates
and Forecasts in US$ Million by Disease Type: 2018-2025
Table 47: Lymphoma Therapeutics Market in Rest of Europe in US$
Million by Disease Type: A Historic Review for the Period
2009-2017
Table 48: Rest of Europe Lymphoma Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 49: Asia-Pacific Lymphoma Therapeutics Market Estimates
and Forecasts in US$ Million by Region/Country: 2018-2025
Table 50: Lymphoma Therapeutics Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2009-2017
Table 51: Asia-Pacific Lymphoma Therapeutics Market Share
Analysis by Region/Country: 2009 VS 2019 VS 2025
Table 52: Lymphoma Therapeutics Market in Asia-Pacific by
Disease Type: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 53: Asia-Pacific Lymphoma Therapeutics Historic Market
Scenario in US$ Million by Disease Type: 2009-2017
Table 54: Asia-Pacific Lymphoma Therapeutics Market Share
Analysis by Disease Type: 2009 VS 2019 VS 2025
AUSTRALIA
Table 55: Lymphoma Therapeutics Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by Disease
Type for the Period 2018-2025
Table 56: Australian Lymphoma Therapeutics Historic Market
Analysis in US$ Million by Disease Type: 2009-2017
Table 57: Australian Lymphoma Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
INDIA
Table 58: Indian Lymphoma Therapeutics Market Estimates and
Forecasts in US$ Million by Disease Type: 2018 to 2025
Table 59: Indian Lymphoma Therapeutics Historic Market Review
by Disease Type in US$ Million: 2009-2017
Table 60: Lymphoma Therapeutics Market in India: Percentage
Share Breakdown of Sales by Disease Type for 2009, 2019, and
2025
SOUTH KOREA
Table 61: Lymphoma Therapeutics Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by Disease
Type for the Period 2018-2025
Table 62: South Korean Lymphoma Therapeutics Historic Market
Analysis in US$ Million by Disease Type: 2009-2017
Table 63: Lymphoma Therapeutics Market Share Distribution in
South Korea by Disease Type: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 64: Rest of Asia-Pacific Market for Lymphoma
Therapeutics: Annual Sales Estimates and Projections in US$
Million by Disease Type for the Period 2018-2025
Table 65: Lymphoma Therapeutics Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Million by Disease Type for the
Period 2009-2017
Table 66: Rest of Asia-Pacific Lymphoma Therapeutics Market
Share Analysis by Disease Type: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 67: Latin American Lymphoma Therapeutics Market Trends by
Region/Country in US$ Million: 2018-2025
Table 68: Lymphoma Therapeutics Market in Latin America in US$
Million by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 69: Latin American Lymphoma Therapeutics Market
Percentage Breakdown of Sales by Region/Country: 2009, 2019,
and 2025
Table 70: Latin American Lymphoma Therapeutics Market Growth
Prospects in US$ Million by Disease Type for the Period
2018-2025
Table 71: Lymphoma Therapeutics Historic Market Analysis in
Latin America in US$ Million by Disease Type: 2009-2017
Table 72: Latin American Lymphoma Therapeutics Market by
Disease Type: Percentage Breakdown of Sales for 2009, 2019, and
2025
ARGENTINA
Table 73: Argentinean Lymphoma Therapeutics Market Estimates
and Forecasts in US$ Million by Disease Type: 2018-2025
Table 74: Lymphoma Therapeutics Market in Argentina in US$
Million by Disease Type: A Historic Review for the Period
2009-2017
Table 75: Argentinean Lymphoma Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
BRAZIL
Table 76: Lymphoma Therapeutics Market in Brazil by Disease
Type: Estimates and Projections in US$ Million for the Period
2018-2025
Table 77: Brazilian Lymphoma Therapeutics Historic Market
Scenario in US$ Million by Disease Type: 2009-2017
Table 78: Brazilian Lymphoma Therapeutics Market Share Analysis
by Disease Type: 2009 VS 2019 VS 2025
MEXICO
Table 79: Lymphoma Therapeutics Market in Mexico: Recent Past,
Current and Future Analysis in US$ Million by Disease Type for
the Period 2018-2025
Table 80: Mexican Lymphoma Therapeutics Historic Market
Analysis in US$ Million by Disease Type: 2009-2017
Table 81: Mexican Lymphoma Therapeutics Market Share Breakdown
by Disease Type: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 82: Rest of Latin America Lymphoma Therapeutics Market
Estimates and Projections in US$ Million by Disease Type: 2018
to 2025
Table 83: Lymphoma Therapeutics Market in Rest of Latin America
by Disease Type: A Historic Review in US$ Million for 2009-2017
Table 84: Rest of Latin America Lymphoma Therapeutics Market
Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 85: The Middle East Lymphoma Therapeutics Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 86: Lymphoma Therapeutics Market in the Middle East by
Region/Country in US$ Million: 2009-2017
Table 87: The Middle East Lymphoma Therapeutics Market Share
Breakdown by Region/Country: 2009, 2019, and 2025
Table 88: The Middle East Lymphoma Therapeutics Market
Estimates and Forecasts in US$ Million by Disease Type: 2018 to
2025
Table 89: The Middle East Lymphoma Therapeutics Historic Market
by Disease Type in US$ Million: 2009-2017
Table 90: Lymphoma Therapeutics Market in the Middle East:
Percentage Share Breakdown of Sales by Disease Type for 2009,
2019, and 2025
IRAN
Table 91: Iranian Market for Lymphoma Therapeutics: Annual
Sales Estimates and Projections in US$ Million by Disease Type
for the Period 2018-2025
Table 92: Lymphoma Therapeutics Market in Iran: Historic Sales
Analysis in US$ Million by Disease Type for the Period
2009-2017
Table 93: Iranian Lymphoma Therapeutics Market Share Analysis
by Disease Type: 2009 VS 2019 VS 2025
ISRAEL
Table 94: Israeli Lymphoma Therapeutics Market Estimates and
Forecasts in US$ Million by Disease Type: 2018-2025
Table 95: Lymphoma Therapeutics Market in Israel in US$ Million
by Disease Type: A Historic Review for the Period 2009-2017
Table 96: Israeli Lymphoma Therapeutics Market Share Breakdown
by Disease Type: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 97: Saudi Arabian Lymphoma Therapeutics Market Growth
Prospects in US$ Million by Disease Type for the Period
2018-2025
Table 98: Lymphoma Therapeutics Historic Market Analysis in
Saudi Arabia in US$ Million by Disease Type: 2009-2017
Table 99: Saudi Arabian Lymphoma Therapeutics Market by Disease
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
Table 100: Lymphoma Therapeutics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Disease Type for the Period 2018-2025
Table 101: United Arab Emirates Lymphoma Therapeutics Historic
Market Analysis in US$ Million by Disease Type: 2009-2017
Table 102: Lymphoma Therapeutics Market Share Distribution in
United Arab Emirates by Disease Type: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 103: Lymphoma Therapeutics Market in Rest of Middle East:
Recent Past, Current and Future Analysis in US$ Million by
Disease Type for the Period 2018-2025
Table 104: Rest of Middle East Lymphoma Therapeutics Historic
Market Analysis in US$ Million by Disease Type: 2009-2017
Table 105: Rest of Middle East Lymphoma Therapeutics Market
Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
AFRICA
Table 106: African Lymphoma Therapeutics Market Estimates and
Projections in US$ Million by Disease Type: 2018 to 2025
Table 107: Lymphoma Therapeutics Market in Africa by Disease
Type: A Historic Review in US$ Million for 2009-2017
Table 108: African Lymphoma Therapeutics Market Share Breakdown
by Disease Type: 2009 VS 2019 VS 2025

IV. COMPETITION

AMGEN
CELGENE CORPORATION
F. HOFFMANN-LA ROCHE AG
JOHNSON & JOHNSON
SEATTLE GENETICS
ASTELLAS PHARMA, INC.
ASTRAZENECA PLC
BRISTOL-MYERS SQUIBB COMPANY
CHUGAI PHARMACEUTICAL
EISAI CO.
ELI LILLY AND COMPANY
FORMA THERAPEUTICS
GLAXOSMITHKLINE PLC
IMMUNOMEDICS
MERCK & CO., INC.
PFIZER, INC
SPECTRUM PHARMACEUTICALS
TRANSGENE SA

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05818005/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001